Previous studies found that GSK3β has been implicated in the regulation of mood-related behaviors and the treatment of antidepressants.57, 58 Our result suggested that selectively decreased Wnt2 and Wnt3 levels might be one of the mechanism underlying the abnormality of GSK3β activity in depression disorder. Here, WNT2 is linked to depressive disorder.